Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2
Background The dedifferentiated variant of chondrosarcoma is highly aggressive and carries an especially grim prognosis. While chemotherapeutics has failed to benefit patients with dedifferentiated chondrosarcoma significantly, preclinical chemosensitivity studies have been limited by a scarcity of...
Guardado en:
Autores principales: | Xiaoyang Li, Dylan C. Dean, Al Ferreira, Scott D. Nelson, Francis J. Hornicek, Shengji Yu, Zhenfeng Duan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4bc285e7b973464fabe3bc6c3e5e7cc4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma
por: Pei Liu, et al.
Publicado: (2017) -
Establishment and Characterization of NCC-DDLPS4-C1: A Novel Patient-Derived Cell Line of Dedifferentiated Liposarcoma
por: Ryuto Tsuchiya, et al.
Publicado: (2021) -
T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma
por: Pichaya Thanindratarn, et al.
Publicado: (2021) -
Integrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression
por: Rémy Nicolle, et al.
Publicado: (2019) -
Dedifferentiation and proliferation of mammalian cardiomyocytes.
por: Yiqiang Zhang, et al.
Publicado: (2010)